Mueller MJ

Psychedelic Research & Therapy Development, Department of Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, Lenggstrasse 31, P.O. Box 363, CH-8032, Zurich, Switzerland.

7 papers · 1 preprint · ORCID

ArticleDMT

Combined DMT-harmine formulation reduces negative self-referential emotions during social self-evaluation: a randomized placebo-controlled trial in healthy volunteers.

Aicher HD, Dornbierer J, Caflisch L +6

Europe PMC2026
ArticleAyahuasca

Ayahuasca-inspired DMT/harmine formulation alters creative thinking dynamics during artistic creation.

Suay D, Aicher HD, Singer B +6

Europe PMC2026
ArticleAyahuasca

Enhancing mindfulness and compassion through an ayahuasca-inspired formulation containing N,N-DMT and harmine: A randomized controlled trial in healthy subjects.

Aicher HD, Wicki IA, Meling D +3

Europe PMC2026
ArticleAyahuasca

Ayahuasca-inspired DMT/HAR formulation reduces brain differentiation between self and other faces.

Suay D, Aicher HD, Kometer M +11

Europe PMC2025
ArticleAyahuasca

Pharmacokinetics and pharmacodynamics of an innovative psychedelic N,N-dimethyltryptamine/harmine formulation in healthy participants: a randomized controlled trial.

Mueller MJ, Aicher HD, Dornbierer DA +16

Europe PMC2024
PreprintAyahuasca

Ayahuasca-Inspired DMT/HAR Formulation Reduces Brain Differentiation Between Self and Other Faces

Suay D, Aicher HD, Kometer M +11

Europe PMC2024
ArticleAyahuasca

Potential therapeutic effects of an ayahuasca-inspired N,N-DMT and harmine formulation: a controlled trial in healthy subjects.

Aicher HD, Mueller MJ, Dornbierer DA +11

Europe PMC2023
ArticleAyahuasca

Overcoming the clinical challenges of traditional ayahuasca: a first-in-human trial exploring novel routes of administration of N,N-Dimethyltryptamine and harmine.

Dornbierer DA, Marten L, Mueller J +11

Europe PMC2023